Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07155057 · ClinicalTrials.gov registry record · NA
Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery
A NA study of Dry Eye Disease (DED), sponsored by Vance Thompson Vision.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07155057: Recruiting NA study of Dry Eye Disease (DED), sponsored by Vance Thompson Vision.
NCT07155057 is a NA study of Dry Eye Disease (DED) that is actively recruiting participants, run by Vance Thompson Vision. The registered enrollment target is 60 participants, below the 471-participant average among 3 other Dry Eye Disease (DED) trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07155057, a NA study of Dry Eye Disease (DED), is actively recruiting participants, sponsored by Vance Thompson Vision.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
To review how patients report using a hyaluronate crosslinked canalicular gel placed before cataract surgery
Primary Outcome
Tear Break-Up time. Tear breakup time (TBUT) is a clinical measurement that assesses the stability of the tear film on the surface of the eye. It measures the time it takes for dry spots to form on the cornea after a complete blink. A rapid breakup indicates tear film instability, which is a common cause of dry eye syndrome. Interpreting TBUT results: A person's TBUT score is an indicator of their tear film health. Normal: A TBUT of 10 seconds or more typically signifies a healthy and stable
Conditions Studied
Interventions
- DEVICE Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML
Study Locations (1)
South Dakota
- Vance Thompson Vision Clinic, Prof. LLC - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-09-03 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07155057 shows while recruiting
NCT07155057 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 471-participant average among 3 other Dry Eye Disease (DED) trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Dry Eye Disease (DED) appearing as the primary indexed condition, and to 1 intervention - of which Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML is the first listed.
NCT07155057 reports a single indexed study location in South Dakota.
Frequently Asked Questions
What is clinical trial NCT07155057 about?
NCT07155057 is a clinical study titled "Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery". To review how patients report using a hyaluronate crosslinked canalicular gel placed before cataract surgery
What is the current status of trial NCT07155057?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-09-03. Estimated completion is 2026-12.
What conditions does trial NCT07155057 study?
This clinical trial studies the following conditions: Dry Eye Disease (DED).
What interventions are being tested in trial NCT07155057?
The interventions under investigation include: Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML (DEVICE).
Who is sponsoring clinical trial NCT07155057?
This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07155057 being conducted?
This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Disease (DED)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)
COMPLETED · Phase 3
-
Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
COMPLETED · Phase 3
-
Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI